DLB — DOLBY LABORATORIES INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying DLB?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their DLB position last quarter, 1 bought and 1 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).
- +1 tracked investor added or increased positions last quarter (Paul Tudor Jones)
- +5 tracked investors reported holding DLB at their latest filing
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About DOLBY LABORATORIES INC (DLB)
DOLBY LABORATORIES INC (DLB) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $31M. Across recent filings, tracked investors recorded 4 new positions, 1 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in DLB
How many top investors track DLB
A small number of top investors own this.
DLB Ownership Composition
How DOLBY LABORATORIES INC is held across tracked investor types, based on reported 13F positions.
- Other95.2%
- Hedge Funds4.8%
Tracked investors reporting DLB
- Izzy EnglanderMar 31, 2026Millennium ManagementShares429.6KValue$25.8M% Portfolio0.01%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares39KValue$2.3M% Portfolio0.00%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares20.6KValue$1.2M% Portfolio0.00%
- Ray DalioDec 31, 2025Bridgewater AssociatesShares25.3KValue$1.6M% Portfolio0.02%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares24.6KValue$1.6M% Portfolio0.00%
Recent activity
- $7MFeb 17, 2026
- $1.2MMay 15, 2026
- New$1.6MFeb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- Increased$1.6M(167.47%)Feb 13, 2026
- New$684.7KNov 13, 2025
Frequently asked questions
- How many institutional investors hold DLB?
- 5 tracked institutional investors disclosed a position in DLB (DOLBY LABORATORIES INC) in their most recent 13F filing.
- Who is the largest institutional holder of DLB?
- Izzy Englander, Millennium Management, holds the largest disclosed position in DLB, valued at $31M.
- Did institutional ownership of DLB increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 1 increased, 0 reduced, and 1 fully exited DLB.
- Where does this DLB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.